Evox Therapeutics secures 1.5 mln pounds
Evox Therapeutics Ltd said March 22 that it secured 1.5 million pounds ($1.98 million) in funding from Innovate UK through the Biomedical Catalyst Early Stage Award. Evox, of the U.K., is an exosome therapeutics company.
22 March 2019•4 mins read
